Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Hepatitis C, Chronic

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benzon, B; Ključević, N; Ključević, Ž; Sutlović, D; Veršić Bratinčević, M1

Other Studies

1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Hepatitis C, Chronic

ArticleYear
Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study.
    Croatian medical journal, 2018, Dec-31, Volume: 59, Issue:6

    Topics: Adult; Analgesics, Opioid; Aspartate Aminotransferases; Cross-Sectional Studies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Platelet Count; Pyrrolidines

2018